Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function.
Anna Jonsson HolmdahlHelena NorbergFredrik ValhamEllinor BergdahlKrister LindmarkPublished in: PloS one (2021)
In this cohort of elderly HFrEF patients with moderately impaired renal function, MRA did not increase risk for WRF or all-cause mortality.
Keyphrases